Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Head and Neck Neoplasms 5Mouth Neoplasms 4Leukoplakia, Oral 3Erythroplasia 3Thyroid Nodule 2Thyroid Neoplasms 2Thyroid Diseases 2Insulin Resistance 2Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Melanoma 1Lymphoid Interstitial Pneumonia 1Leukoplakia 1Laryngeal Diseases 1Hyperplasia 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Squamous Cell Cancer 1Endometrial Neoplasms 1Diabetes Mellitus, Type 2 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Breast Diseases 1Adenocarcinoma Of Esophagus 1

Interventions

Cetuximab 2Alpelisib 2toripalimab 1sintilimab 1rocakinogene sifuplasmid 1raltitrexed 1cabozantinib 1VGX-3100 1Radiotherapy, Intensity-Modulated 1Metformin 1MEDI0457 1Fluorouracil 1Cisplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Squamous Cell Cancer × Metformin × Head & Neck × Clear all
NCT02083692 2025-05-15

Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
50 enrolled
Head & Neck

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡